Stay updated on Long-term Safety of UCART19 in Lymphoid Leukemia Clinical Trial
Sign up to get notified when there's something new on the Long-term Safety of UCART19 in Lymphoid Leukemia Clinical Trial page.

Latest updates to the Long-term Safety of UCART19 in Lymphoid Leukemia Clinical Trial page
- Check3 days agoChange DetectedA site-wide banner announces changes to NIH website terminology, including a notice about using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check10 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.1 to v3.7.2, while the study page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check31 days agoChange DetectedA 403 Forbidden error page is now shown for the study record, including a 403 header and a Home link, indicating access is blocked to the page.SummaryDifference0.5%

- Check38 days agoChange DetectedA 403 Forbidden error page appears on the study record, replacing the study details and related links. This blocks access to the core information about the study, including its title, conditions, locations, and contacts.SummaryDifference16%

- Check59 days agoChange DetectedAdded a 2016 U.S. NIH Grant/Contract identifier to the study's Other Study ID Numbers, providing funding context for the record. The page's revision metadata was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

Stay in the know with updates to Long-term Safety of UCART19 in Lymphoid Leukemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Safety of UCART19 in Lymphoid Leukemia Clinical Trial page.